Pathogenesis of cerebral amyloid angiopathy caused by chaotic glymphatics-Mini-review

Forshing Lui1, Jessa Alcaide1, Stella Knowlton1

  • 1Department of Clinical Sciences, California Northstate University College of Medicine, Elk Grove, CA, United States.

Insights

Cerebral amyloid angiopathy (CAA) involves amyloid beta (Aβ) deposition in brain arteries. This study proposes a retrograde transport mechanism for Aβ, potentially linked to glymphatic system disturbances, to explain CAA pathogenesis.

Area of Science:

  • Neurology
  • Pathology
  • Neuroscience

Background:

  • Cerebral amyloid angiopathy (CAA) is a significant cause of intracerebral hemorrhage in older adults.
  • CAA shares amyloid beta (Aβ) deposition pathology with Alzheimer's disease (AD), but Aβ localization differs (vascular walls in CAA vs. neurites in AD).
  • The precise mechanism of Aβ deposition in cerebral arterial walls in CAA remains poorly understood.

Purpose of the Study:

  • To investigate the pathogenesis of cerebral amyloid angiopathy (CAA).
  • To elucidate the mechanism of amyloid beta (Aβ) fibril deposition in cerebral and meningeal arterial walls.
  • To explore the potential role of glymphatic system dysfunction in CAA.

Main Methods:

  • Case study of aneurysmal subarachnoid hemorrhage followed by localized CAA.
  • Review of amyloid beta (Aβ) formation and transport pathways.
  • Postulation of a retrograde transport mechanism for Aβ in CAA.

Main Results:

  • An unusual case presented with subarachnoid hemorrhage followed by localized CAA.
  • A hypothesis for retrograde Aβ transport from brain parenchyma to arterial walls was proposed.
  • Disturbances in the glymphatic system, aquaporin-4 channels, and parenchymal border macrophages were noted.

Conclusions:

  • The study proposes a novel retrograde transport mechanism for amyloid beta (Aβ) in the pathogenesis of cerebral amyloid angiopathy (CAA).
  • Glymphatic system dysfunction and associated cellular components may play a critical role in CAA development.
  • Further research is warranted to validate the proposed Aβ transport pathway and its clinical implications.